Jaye L. Thompson
Hoofd Techniek/Wetenschap/O&O bij GREENWICH LIFESCIENCES, INC.
Vermogen: 3 M $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Eric Rothe | M | 49 | 18 jaar | |
| Snehal Patel | M | 60 | 14 jaar | |
| David McWilliams | M | 80 | 15 jaar | |
| F. Daugherty | M | 73 | 5 jaar | |
| Kenneth Hallock | M | 75 | 5 jaar | |
| Christine T. Fischette | M | - | 3 jaar | |
| Fernando Martinez | M | - |
inVentiv Clinical Solutions LLC
| 16 jaar |
| Walter Ulrich | M | - |
Gulf Coast Regional Center of Innovation & Commercialization
| - |
| Joachim F. Wernicke | M | 76 | 11 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Joseph S. Podolski | M | 76 | 28 jaar | |
| Larry Dillaha | M | 60 | 1 jaar | |
| Jean L. Fourcroy | M | 93 | 9 jaar | |
| David Hung | M | 67 |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 5 jaar |
| Patrick P. Fourteau | M | 77 | 2 jaar | |
| Gail Maderis | F | 66 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 6 jaar |
| Michael Wyllie | M | 73 | 7 jaar | |
| Donald Healey | M | 62 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 7 jaar |
| Kenny S. Frazier | M | - |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | - |
| Sona Saira Ramasastry | F | 48 | 5 jaar | |
| Mark Lappe | M | 57 | 1 jaar | |
| Ronald D. Wiehle | M | 75 | 19 jaar | |
| Karthik Radhakrishnan | M | 53 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 jaar |
| Donald Tredway | M | - | - | |
| Michael Suesserman | M | 59 | 2 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 24 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Jaye L. Thompson
- Persoonlijk netwerk